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Serum carotenoids and Pediatric 
Metabolic Index predict insulin 
sensitivity in Mexican American 
children
Srinivas Mummidi1,11*, Vidya S. Farook1,11, Lavanya Reddivari2,11, Joselin Hernandez‑Ruiz3, 
Alvaro Diaz‑Badillo1, Sharon P. Fowler4, Roy G. Resendez1, Feroz Akhtar1, 
Donna M. Lehman5, Christopher P. Jenkinson1, Rector Arya1, Jane L. Lynch6, Jose A. Canas7, 
Ralph A. DeFronzo5, Daniel E. Hale8, John Blangero1, Juan Carlos Lopez‑Alvarenga1, 
Ravindranath Duggirala1 & Jairam K. P. Vanamala9,10*
High concentrations of carotenoids are protective against cardiometabolic risk traits (CMTs) in 
adults and children. We recently showed in non‑diabetic Mexican American (MA) children that serum 
α‑carotene and β‑carotene are inversely correlated with obesity measures and triglycerides and 
positively with HDL cholesterol and that they were under strong genetic influences. Additionally, we 
previously described a Pediatric Metabolic Index (PMI) that helps in the identification of children who 
are at risk for cardiometabolic diseases. Here, we quantified serum lycopene and β‑cryptoxanthin 
concentrations in approximately 580 children from MA families using an ultraperformance liquid 
chromatography‑photodiode array and determined their heritabilities and correlations with CMTs. 
Using response surface methodology (RSM), we determined two‑way interactions of carotenoids and 
PMI on Matsuda insulin sensitivity index (ISI). The concentrations of lycopene and β‑cryptoxanthin 
were highly heritable  [h2 = 0.98, P = 7 × 10–18 and  h2 = 0.58, P = 1 × 10–7]. We found significant (P ≤ 0.05) 
negative phenotypic correlations between β‑cryptoxanthin and five CMTs: body mass index 
(− 0.22), waist circumference (− 0.25), triglycerides (− 0.18), fat mass (− 0.23), fasting glucose 
(− 0.09), and positive correlations with HDL cholesterol (0.29). In contrast, lycopene only showed 
a significant negative correlation with fasting glucose (− 0.08) and a positive correlation with HDL 
cholesterol (0.18). Importantly, we found that common genetic influences significantly contributed 
to the observed phenotypic correlations. RSM showed that increased serum concentrations of 
α‑ and β‑carotenoids rather than that of β‑cryptoxanthin or lycopene had maximal effects on ISI. 
In summary, our findings suggest that the serum carotenoids are under strong additive genetic 
influences and may have differential effects on susceptibility to CMTs in children.
Obesity or overweight affects one in three children in the United  States1 and is associated with other comorbid 
conditions such as insulin resistance, hypertension, non-alcoholic fatty liver disease, obstructive sleep apnea, 
dyslipidemia, and psycho-behavioral  problems2–9. A major concern is that about 70% of these children are at 
risk of developing adult obesity that predisposes them to develop several chronic diseases, including metabolic 
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syndrome (MS)10,11. Growing evidence suggests that the accumulation of adipose tissue resulting from a positive 
energy balance leads to a low-grade pro-inflammatory state and oxidative  stress12,13. There are marked dispari-
ties in adult and childhood obesity between various ethnic groups with increased prevalence in Hispanics and 
African  Americans14, which are most likely due to environmental and genetic factors and their  interactions15,16.
Fruits and vegetables contain phytonutrients such as carotenoids, which are considered anti-obesogenic due 
to their anti-inflammatory and anti-oxidant  properties17,18. Carotenoid functionality is most likely mediated 
through modulation of inflammation-related gene transcription and signal transduction pathways and scav-
enging reactive oxygen  species17,19–23. While the U.S. Department of Health and Human Services recommends 
daily fruit and vegetable  consumption24, ~ 60% of children aged 1 to 18 years do not meet the suggested levels of 
intake of 1–2 cups of fruits and 1–3 cups of  vegetables25 and often low socioeconomic status compromises the 
quality of their  diet26. Although Hispanic children and adolescents may have higher fruit and vegetable intake 
compared with African–American and white  youth27, their relative serum carotenoid concentrations could be 
 variable28, suggesting that additional factors should be taken into consideration for understanding metabolic 
dysfunction in this high-risk population.
Six carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein, and zeaxanthin) constitute > 95% 
of the circulating carotenoids in the human  body29,30. Chemically, carotenoids are lipophilic polyisoprenoid 
compounds that are either hydrocarbons (α-carotene, β-carotene, lycopene) or the oxygenated xanthophylls 
(β-cryptoxanthin, lutein, zeaxanthin)30. Among these, α-carotene, β-carotene and β-cryptoxanthin, are con-
sidered to be provitamin A carotenoids. As their name implies, they can be further metabolized to retinol and 
related compounds that function as Vitamin A, which is involved in growth, development, and visual  function31. 
Lycopene, lutein, and zeaxanthin are non-vitamin A carotenoids, of which the latter two are intimately involved 
in blue light filtering in the macular region of the  retina32. Lycopene is the most efficient singlet oxygen quencher 
among the carotenoids mentioned  above33.
Humans cannot synthesize carotenoids and rely on the dietary intake of fruits and vegetables for their supply. 
There is substantial inter-individual variability in serum and tissue carotenoid levels. Several factors, includ-
ing age, gender, body weight, physical activity, alcohol consumption, drug use, smoking status, and infectious 
diseases, may determine this inter-individual  variability34. Also, several candidate-association and genome-
wide association studies have identified genetic variants that could potentially influence carotenoid levels and 
bioavailability by altering their absorption, cleavage, transport, metabolism, and tissue  incorporation35–38. The 
genetic basis for inter-individual variation in carotenoids in Mexican Americans is poorly understood. Our 
recent data showed that serum levels of α-carotene and β-carotene are under strong genetic additive influences 
in Mexican American children who were at high risk for overweight (53%), obesity (34%), prediabetes (13%), 
and metabolic syndrome (19%)39,40 and that they have phenotypic correlations with several cardiometabolic risk 
traits (CMTs)39. Our recent studies also demonstrated that genetic factors might influence positive phenotypic 
correlations between β-carotene and HDL cholesterol and negative phenotypic correlation between β-carotene 
and waist circumference and body mass  index39. In the current study, our primary objective was to examine 
the genetic basis of lycopene and β-cryptoxanthin variability among these children and their correlation with 
CMTs. Importantly, we assessed the interactions between the four carotenoids and a Pediatric Metabolic Index 
(PMI) which, incorporates adiposity and lipid measures in predicting insulin sensitivity using the response 
surface methodology.
Materials and methods
Subjects. The current study is a family-based cross-sectional study in Mexican American children to deter-
mine the heritability of two different carotenoids, β-cryptoxanthin and lycopene, and their association with 
CMTs. The participants of this study were Mexican American children and adolescents (N = 673, age 6–17 years 
old), who were recruited as part of the San Antonio Family Assessment of Metabolic Risk Indicators (SAFARI) 
 study40. These children were from 401 MA nuclear families/sibships, which were embedded within extended 
families that we recruited previously as part of three well established genetic epidemiological studies in San 
Antonio, TX, and  vicinity40. Many of the children belonged to predominantly low-income extended families. 
Each nuclear family/sibship had ~ 2 children (range 1–5 children), and the children from all the families gener-
ated a total of 3664 relative pairs. As described previously, this study aimed to assess CMTs and their genetic and 
environmental bases in MA children in San Antonio, Texas. The present study excluded three children who had 
type 2 diabetes; thus, it involved 670 non-diabetic children. The Institutional Review Board of the University 
of Texas Health, San Antonio, Texas, reviewed and approved all the research protocols. For each child, written 
informed consent was obtained from one or both parents, and for children seven years or older, a signed assent 
was obtained. All studies were performed in accordance with the relevant guidelines and regulations.
Phenotype data. Extensive information such as family history, socio-demographic characteristics, and 
environmental data were collected using questionnaires at the clinic or home interviews as described in detail 
 previously40. All physical, clinical, and laboratory assessments were performed at the Children’s Center of the 
Texas Diabetes Institute (TDI), and some laboratory assessments using serum samples were carried out at the 
Texas Biomedical Research Institute, San Antonio, TX, the USA. as previously  reported40. Aliquots of biospeci-
mens (e.g., fasting serum samples) collected at the same clinic visits of the children were prepared and promptly 
frozen at − 70 ºC for future use. The following ten obesity-related quantitative traits were used for estimating the 
phenotypic, genetic, and environmental correlations with serum carotenoid levels: waist circumference, body 
mass index (BMI), fat mass assessed by dual X-ray absorptiometry (DXA), blood pressure [systolic (SBP) and 
diastolic blood pressure (DBP)], fasting plasma glucose, fasting serum specific insulin, the homeostasis model 
of assessment-insulin resistance (HOMA-IR), HDL cholesterol (HDL-C), and triglycerides. As described pre-
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viously, serum carotenoids were measured with the available serum samples using Waters’ ultra-performance 
liquid chromatography-photodiode array (UPLC-PDA)39. The carotenoid standards were obtained from Sigma-
Aldrich (Saint Louis, MO, USA). The α- and β-carotenoid data were previously  reported39, and measurements 
of lycopene and β-cryptoxanthin were obtained for this study (N =  ~ 580). Both dietary intake of carotenoid 
levels as assessed by the self-reported Block Kids Food Frequency Questionnaire (FFQ) and serum carotenoid 
data were available for a subset of our SAFARI children (N =  ~ 440). The obtained FFQ information was based 
on 78 questions regarding the consumption of food/beverage items (frequency and amounts consumed) in the 
previous  week41,42. The Block FFQs were analyzed by NutritionQuest (Berkeley, CA). Adjustments were made to 
carotenoid concentrations using age, sex, ln BMI, total energy intake (kcals), and total cholesterol as covariates 
to assess correlations between dietary intake of carotenoid and serum carotenoid  levels43,44.
Statistical analyses. Variance components analysis. The genetic basis of lycopene and β-cryptoxanthin 
were determined using a variance-components approach (VCA) as implemented in the computer program 
 SOLAR45. Briefly, in a simple model, variances or covariances between relatives as a function of the genetic 
relationships can be specified, and the proportion of phenotypic variance that is attributed to (additive) genetic 
influences (i.e., heritability,  h2) is estimated from the components of variance. A likelihood ratio test was used to 
test whether the heritability of a given carotenoid was significant (P ≤ 0.05). The lycopene and β-cryptoxanthin 
values were inverse normalized for the genetic analyses, and all analyses accounted for covariate effects (e.g., age 
and sex). We reanalyzed the data to determine the heritability estimate of a given carotenoid after accounting for 
the dietary intake of the same carotenoid as an additional covariate using a sub-set of our data.
Bivariate genetic analysis. Bivariate genetic analysis was used to determine the phenotypic, genetic, and envi-
ronmental correlations between the carotenoids and the ten CMTs. In this approach, a given phenotypic cor-
relation (ρP) between a pair of phenotypes (e.g., lycopene and BMI) is partitioned into additive genetic (ρG) and 
environmental (ρE) correlations. The phenotypic correlation (ρP) between a pair of traits is given by:
where ρP = the phenotypic correlation; ρG = the additive genetic correlation; ρE = the random environmental cor-
relation; h2
1
 = the heritability of trait 1; h2
2
 = the heritability of trait 2; e2
1




 = equal to 1 − h2
2
 . The 
significance (P ≤ 0.05) of the phenotypic, additive genetic, and random environmental correlation was determined 
using likelihood ratio tests. The additive genetic correlation (ρG) is a measure of the shared genetic basis of the 
two traits (i.e., pleiotropy).
Pediatric Metabolic Index (PMI). PMI was based on two different adiposity-related components obtained from 
396 Mexican  children46. It was shown to be correlated well with HOMA-IR, Matsuda ISI, and hepatic enzymes 
and could be used to identify children who are at increased risk for cardiometabolic diseases. The first compo-
nent of PMI was based on the distribution of adipose tissue, and the second component was based on adipose 
dysfunction. For the second component, median values from the normal-weight children in the population 






The abbreviations in the above equations are defined as follows: TG = fasting triglycerides (mmol/L); HDL-C: 
HDL cholesterol (mmol/L); WC = waist circumference (cm); and BMI = Body Mass Index expressed as Z-score). 
Age is in years.
Response surface methodology (RSM). The response surface analysis with quadratic effects was used to deter-
mine two-way interactions of serum carotenoids and PMI on Matsuda insulin sensitivity index (ISI), a better 
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Results
Serum carotenoid levels are highly heritable. A total of 670 non-diabetic children were included in 
the study after excluding three children with T2D. The serum levels of lycopene and β-cryptoxanthin were highly 
heritable (lycopene,  h2 = 0.98, P = 7.3 × 10–18; β-cryptoxanthin,  h2 = 0.58, P = 1 × 10–7). We repeated the heritabil-
ity analysis of a given trait after adjusting for dietary intake of the same carotenoid using a subset of our data 
based on the availability of the dietary information. Prior to the reanalysis of the data, we found low but signifi-
cant correlations between dietary intake of carotenoids and serum carotenoid levels as follows: β-cryptoxanthin 
(ρ ± S.E., P-value): 0.14 ± 0.05, 0.003 and lycopene: 0.17 ± 0.05, 0.0004. However, our reanalyzed data revealed 
minimal changes in our heritability estimates, in turn suggesting that the original heritability estimates of 
β-cryptoxanthin and lycopene are largely related to post-absorption-derived concentrations of carotenoids. We 
previously published the heritabilities of the CMTs as well as the serum α-carotene and β-carotene levels from 
SAFARI  children39,40 and are included in Table 1 to aid in data description and additional analyses and inter-
pretation.
Serum carotenoid levels show different patterns of correlations with CMTs. The results of phe-
notypic (ρP), genetic (ρG), and environmental (ρE) correlations between lycopene and β-cryptoxanthin and the 
CMTs are shown in Fig. 1 and Tables 2, 3. For comparative purposes, we also included our previously published 
data on α-carotene (Fig. 1A) and β-carotene (Fig. 1B). Both β-cryptoxanthin and lycopene showed a significant 
positive correlation with HDL-C. However, for the other traits, the two carotenoids showed distinct phenotypic 
and genetic correlations. As shown in Table  2, a significant negative phenotypic correlation (ρP) was found 
between lycopene and fasting glucose (ρP  = − 0.08; for example, with each S.D. increment of lycopene, the fast-
ing glucose decreased by 5 mg/dL). In contrast, the ρP between lycopene and HDL-C was positive (ρP = 0.18; 
for example, for each S.D. increment of lycopene, HDL-C increased by 2.1 mg/dL) and significant. Likewise, as 
shown in Table 3, β-cryptoxanthin exhibited a significant positive ρP of 0.29 with HDL-C. However, it exhibited 
significant negative ρPs with waist circumference, BMI, triglycerides, and fat mass, which ranged from − 0.25 
(waist circumference) to − 0.18 (triglycerides). When the ρPs were partitioned into ρGs and ρEs, only ρGs between 
β-cryptoxanthin and waist circumference (− 0.34), B.M.I. (− 0.30), triglycerides (− 0.44), and HDL-C (0.62), but 
not ρEs with the same traits, were statistically significant. In the case of lycopene, only the ρG with HDL-C was 
significant. When corrected for multiple testing using the Benjamini–Hochberg  procedure47, only the pheno-
typic correlation with HDL-C remained significant for lycopene (i.e., Benjamini–Hochberg procedure-based 
False Discovery Rate (FDR) adjusted P-value < 0.02 corresponds to a nominal P-value < 0.05). In the case of 
β-cryptoxanthin, the phenotypic correlations with waist circumference, BMI, HDL-C, triglycerides, fat mass, 
Table 1.  Characteristics of the 670 non-diabetic SAFARI children and heritability estimates for selected 
cardiometabolic risk traits and carotenoids. BMI, body mass index; DXA, dual X-ray absorptiometry, 
HOMA-IR. the homeostasis model of assessment-insulin resistance; HDL cholesterol, high-density lipoprotein 
cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure. a MS = metabolic syndrome as defined in 
Fowler et al.40. b Traits were inverse-normalized for the genetic analyses. c Traits were adjusted for the significant 
covariate effects of age and sex terms for the genetic analyses.
Variable N Mean ± SD or% h2 ± SE P-value References
Girls 670 49.3 – – –
Age (years) 670 11.5 ± 3.5 – – –
Overweight 670 52.7 – – –
Obese 670 33.6 – – –
Pre-diabetes 630 13.2 – – –
MSa 625 18.7 – – –
Acanthosis nigricans 661 33.1 – – –
BMI (kg/m2) 670 22.7 ± 6.5 0.75 ± 0.11 1.1 × 10–11 Fowler et al.40
Waist circumference (mm) 664 764.5 ± 179.7 0.63 ± 0.12 3.0 × 10–8 Fowler et al.40
Fat mass (kg) [DXA] 634 16.0 ± 11.1 0.69 ± 0.12 1.8 × 10–9 Fowler et al.40
Fasting glucose (mg/dl) 630 89.5 ± 7.5 0.39 ± 0.11 6.3 × 10–5 Fowler et al.40
Fasting insulin (µIU/ml) 626 13.6 ± 9.4 0.55 ± 0.11 2.0 × 10–7 Fowler et al.40
HOMA-IR 622 2.0 ± 1.3 0.60 ± 0.11 1.8 × 10–8 Fowler et al.40
HDL cholesterol (mg/dl) 623 45.8 ± 10.9 0.64 ± 0.12 2.9 × 10–8 Fowler et al.40
Triglycerides (mg/dl) 623 74.9 ± 39.8 0.77 ± 0.11 8.8 × 10–13 Fowler et al.40
SBP (mmHg) 670 104.1 ± 9.7 0.66 ± 0.11 1.0 × 10–10 Fowler et al.40
DBP (mmHg) 670 63.2 ± 7.0 0.64 ± 0.11 9.7 × 10–10 Fowler et al.40
α-carotene (µmol/L)b,c 565 0.60 ± 0.97 0.81 ± 0.12 6.7 × 10−11 Farook et al.39
β-carotene (µmol/L)b,c 572 0.48 ± 0.59 0.90 ± 0.11 3.6 × 10−15 Farook et al.39
Lycopene (µmol/L)b,c 590 0.41 ± 0.58 0.98 ± 0.10 7 × 10–18 This study
β-cryptoxanthin (µmol/L)b,c 593 0.51 ± 0.42 0.58 ± 0.12 1 × 10–7 This study
5
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and systolic blood pressure and genotypic correlations with HDL-C and triglycerides remained significant after 
FDR correction. For explanation, a positive genetic correlation between two traits indicates that the same genetic 
factors increase (or decrease) their levels. In contrast, a negative correlation between the two traits indicates that 
the same genetic factors increase the levels of one trait and decrease the levels of the other trait.
Differential interactions of individual serum carotenoid levels with insulin sensitivity. We used 
RSM to determine two-way interactions of serum carotenoids and PMI on Matsuda ISI. RSM generates a surface 
Figure 1.  Genetic correlation coefficients (ρG) from α-carotene (A), β-carotene (B), β-cryptoxanthin (C), 
and lycopene (D) and their correlation with CMTs. The solid dots show the estimated rho coefficient; bars 
correspond to 95% confidence intervals, and the dotted vertical line corresponds to the absence of correlation 
(ρG = 0). Both carotenoids show a positive correlation with HDL-C. Several obesity-related traits showed a 
negative correlation with β-carotene and β-cryptoxanthin. If the FDR correction is applied, the significant 
P-value threshold is < 0.02 (corresponding to a nominal P-value < 0.05). For simplicity, the data for SBP and DBP 
are not shown.
Table 2.  Phenotypic (ρP), genetic (ρG) and environmental (ρE) correlations between lycopene and the 
cardiometabolic risk traits. HDL cholesterol, high-density lipoprotein cholesterol, HOMA-IR the homeostasis 
model of assessment-insulin resistance. Asterisks indicate the p-values that remain significant after applying 
FDR correction. Bold values denote statistical significance at P-value ≤ 0.05. a All traits were adjusted for 
the covariate effects of age and sex terms. b Data were log-transformed. c Trait was transformed using inverse 
normal transformation.
Trait  paira ρP (95% CI) P-value ρG (95% CI) P-value ρE (95% CI) P-value
Waist circumference − 0.05 (− 0.128, 0.028) 0.24 − 0.06 (− 0.295, 0.175) 0.61 − 0.02 (− 1,1) 0.97
Body Mass  Indexb − 0.04 (− 0.138, 0.058) 0.35 − 0.06 (− 0.276, 0.156) 0.61 0.06 (− 1,1) 0.93
HDL cholesterol 0.18 (0.102, 0.258) 5.69 × 10–5* 0.24 (0.005, 0.475) 0.05 − 0.08 (− 1, 0.998) 0.87
Triglyceridesb − 0.03 (− 0.128, 0.068) 0.51 − 0.1 (− 0.316, 0.116) 0.39 0.47 (− 1,1) 0.46
Fat  massb − 0.03 (− 0.128, 0.068) 0.52 − 0.01 (− 0.245, 0.225) 0.91 − 0.14 (− 1,1) 0.82
Systolic blood pressure − 0.03 (− 0.108, 0.048) 0.53 − 0.04 (− 0.275, 0.195) 0.70 0.066 (− 0.9728,1) 0.90
Diastolic blood pressure − 0.03 (− 0.108, 0.048) 0.54 − 0.02 (− 0.255, 0.215) 0.89 − 0.03 (− 1,1) 0.58
Fasting  glucoseb − 0.08 (− 0.158, − 0.002) 0.04 − 0.25 (− 0.544, 0.044) 0.09 0.33 (− 0.67,1) 0.38
Fasting  insulinb 0.01 (− 0.068, 0.088) 0.78 0.17 (− 0.065, 0.405) 0.18 − 0.72 (− 1, 0.828) 0.12
HOMA-IRc 0.02 (− 0.058, 0.098) 0.70 0.13 (− 0.105, 0.365) 0.27 − 0.59 (− 1, 0.821) 0.24
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fitted three-dimensional plot using a distance-weighted least-squares procedure while minimizing the variance 
of estimators by a polynomial regression model weighted for the inverse of the variances. The plots shown in 
Fig. 2 represent the interactions between serum carotenoid concentrations with PMI while showing the extent 
of insulin sensitivity measured by Matsuda ISI. Interestingly, the resulting function is nonlinear, and a maximum 
response was obtained with increasing serum α- and β- carotenoids (Fig. 2A,B), but not with β-cryptoxanthin 
or lycopene (Fig. 2C,D). However, there is a significant decrease in Matsuda ISI with lower levels of α- and 
β-carotenoids. PMI values between 2 and 4 showed the maximum variability associated with carotenoids.
Discussion
Our family-based study demonstrates that genetic factors play a crucial role in determining the serum carot-
enoid concentrations in MA children. Similarly, several other studies reported a range of heritabilities for 
 carotenoids39,48–50, given that the heritability is a population-specific parameter. For example, high heritability 
 (r2 = 0.98) has been reported for relative peak macular pigment density in monozygotic  twins51 and moderate 
heritability  (h2 = 30.5%) for serum retinol levels in a French family  study49. A recent study in Older Order Amish 
adults estimated the heritability of serum lycopene to be 0.38 ± 0.1248. While it can be argued that shared environ-
mental influences could have resulted in high heritabilities observed in our study, we believe that these estimates 
are plausible as most of the children are distributed across large families. These findings are similar to those we 
found for the α-carotene and β-carotene in the same group of  children39. The serum levels of β-cryptoxanthin 
and lycopene consistently showed a positive correlation with HDL-C levels while there was a marked differ-
ence in their effects on other CMTs. We previously observed a similar correlation between serum α-carotene 
and β-carotene and HDL-C39. These results are in agreement with the concept that plasma lipoproteins as the 
primary transporters of  carotenoids52.
Given that diet is the primary source of serum carotenoids, based on our available data, we assessed the extent 
to which the observed high heritabilities are related to the dietary intake of carotenoids in our study. Despite 
the limitations of the FFQ derived estimates of dietary markers, including carotenoids, we found low but highly 
significant correlations between dietary and serum carotenoids after making appropriate covariate adjustments. 
Here, it is worth noting that there is no consensus on the nature of the relationship between dietary intake 
and blood (either serum or plasma) carotenoid  concentrations43,44,53–55. Also, such relationships may differ by 
individual  carotenoids43. Moreover, blood concentrations of carotenoids may be able to better predict disease 
risk when compared to dietary  intake56. However, our findings of minimal changes in heritability estimates of 
carotenoids after adjustments for dietary carotenoids suggest that the observed high heritabilities are mainly 
related to post-absorption-derived concentrations of carotenoids. This conclusion may not be that surprising 
since many other factors, aside from diet, related to carotenoid uptake, distribution, metabolism, and excretion, 
contribute to their levels in the  body34. Also, it should be noted that carotenoids have long and variable half-lives 
and follow first-order depletion  kinetics57.
In this study, β-cryptoxanthin showed a negative correlation with several CMTs, including waist circumfer-
ence, BMI, triglycerides, and fat mass, but lycopene failed to show any correlation with any of the examined 
CMTs. Despite strong evidence for the possible role of lycopene in the suppression of adipogenesis, there are 
conflicting reports on the correlation between lycopene and BMI and related  traits28,58. Notwithstanding the 
Table 3.  Phenotypic (ρP), genetic (ρG) and environmental (ρE) correlations between β-cryptoxanthin and the 
cardiometabolic risk traits. HDL cholesterol, high-density lipoprotein cholesterol, HOMA-IR the homeostasis 
model of assessment-insulin resistance. Asterisks indicate the p-values that remain significant after applying 
FDR correction. Bold values denote statistical significance at P-value ≤ 0.05. a All traits were adjusted for 
the covariate effects of age and sex terms. b Data were log-transformed. c Trait was transformed using inverse 
normal transformation.
Trait  paira ρP (95% CI) P-value ρG (95% CI) P-value ρE (95% CI) P-value
Waist circumference − 0.25 (− 0.328, − 0.172) 2.93 × 10
–9* − 0.34 (− 0.595, − 0.085) 0.02 − 0.1 (− 0.551, 0.351) 0.67
Body Mass  Indexb − 0.22 (− 0.2984, − 0.142) 2.08 × 10
–7* − 0.3 (− 0.555, − 0.045) 0.03 − 0.06 (− 0.589, 0.469) 0.82
HDL cholesterol 0.29 (0.212, 0.368) 1.32 × 10–12* 0.62 (0.346, 0.894) 5.75 × 10–5* − 0.19 (− 0.641, 0.261) 0.35
Triglyceridesb − 0.18 (− 0.258, − 0.102) 5.30 × 10
–5* − 0.44 (− 0.714, − 0.166) 0.002* 0.36 (− 0.189, 0.909) 0.14
Fat  massb − 0.23 (− 0.308, − 0.152) 1.7 × 10
–7* − 0.27 (− 0.525, − 0.015) 0.054 − 0.16 (− 0.611, 0.291) 0.51
Systolic blood pressure − 0.07 (− 0.148, 0.008) 0.01* − 0.13 (− 0.424, 0.164) 0.35 0.03 (− 0.362, 0.422) 0.87
Diastolic blood pres-
sure − 0.07 (− 0.148, 0.008) 0.10 − 0.18 (− 0.474, 0.114) 0.23 0.1 (− 0.292, 0.492) 0.60
Fasting  glucoseb − 0.09 (− 0.168, − 0.0116) 0.04 − 0.3 (− 0.692, 0.092) 0.12 0.09 (− 0.204, 0.384) 0.54
Fasting  insulinb − 0.07 (− 0.148, 0.008) 0.10 0.27 (− 0.024, 0.564) 0.15 − 0.56 (− 0.932, − 0.188) 0.002
HOMA-IRc − 0.07 (− 0.148, 0.008) 0.11 0.21 (− 0.084, 0.504) 0.16 − 0.52 (− 0.932, − 0.108) 0.009
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observation that BMI could influence the association between metabolic syndrome and serum lycopene levels, 
the associations between lycopene and the metabolic syndrome were only significant for normal-weight and 
participants who are overweight and not for individuals with obesity in the adult National Health and Nutrition 
Examination Survey (NHANES)  data59. A previous study reported higher serum concentrations of α-tocopherol, 
α-carotene, and trans-β-carotene in Mexican American children were associated with reduced childhood 
overweight and  obesity60. While similar associations were found in the SAFARI children with α-carotene and 
β-carotene39, our current study further extends these observations to include β-cryptoxanthin suggesting an 
overall beneficial effect of serum levels of these three carotenoids.
In a systemic review of multiple studies conducted on anti-oxidant vitamins, Asplund showed that lower 
cardiovascular risk is associated with high intake of β-carotene (OR = 0.88; 95%CI 0.77–1.01) or high serum/
plasma levels of β-carotene (OR = 0.46; 95%CI 0.37–0.58) whereas such effect is not seen in randomized con-
trolled trials with β-carotene supplements (OR = 1.02; 95%CI 0.96–1.08)61. Additional studies also have shown 
that serum carotenoids have anti-oxidant activity, and low levels of serum carotenoids and other anti-oxidants 
are associated with insulin resistance, T2D, and metabolic  syndrome62–70. Kinetic analysis of plasma carotenoid 
concentrations shows extreme variability in absorption curves and plasma clearance  rates71. While the mecha-
nism of intracellular translocation of carotenoids is not completely understood, recent studies have shown that in 
addition to passive diffusion, transporters such as SR-BI may play a role in their  absorption72. Nevertheless, the 
overall carotenoid bioaccessibility is considered to be poor and variable among individuals, and such variability 
may contribute to the carotenoid “low responder” and “high responder”  phenotypes72. Additional factors such 
as dietary fiber content and composition of gut microbiota may also alter carotenoid absorption, bio-activation, 
Figure 2.  Response surface contour plots showing the relationship of α-carotene (A), β-carotene (B), 
β-cryptoxanthin (C), and lycopene (D) and PMI with Matsuda ISI. The contour plots are colored to aid in better 
visualization of the graphics.
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and circulating plasma concentrations. How consumption of carotenoids can regulate gut immune responses 
and microbiota is a subject of active ongoing  research73.
We initially developed PMI as an omnibus clinical measure that included adiposity, HDL-C, and triglyceride 
concentration to assess the relative metabolic health of children in a population after adjusting for age and sex. 
Remarkably, we found that serum α- and β- carotenoid concentrations were inversely associated with PMI in 
the SAFARI children using the RSM approach. However, their protective effects were modified by underlying 
metabolic conditions and were diminished in the presence of metabolic impairment (PMI > 4). Some previous 
studies showed both dietary and plasma β-carotene, but not lycopene and β-cryptoxanthin, may positively 
associate with insulin sensitivity. Sluijs et al. reported that diets high in β-carotene were protective against T2D 
[Hazard Ratio quartile 4 versus quartile 1 (HRQ4): 0.78 (95%CI 0.64, 0.95), P-linear trend 0.01]67. In contrast, 
they found that the effect of serum α-carotene on T2D was marginal [HRQ4 of 0.85 (95%CI 0.70,1.03), and 
P-linear trend 0.05], whereas other carotenoids did not show any association. In a study conducted on non-
diabetic adult subjects with obesity, plasma β-carotene concentrations were positively associated with insulin 
sensitivity, as assessed by HOMA-IR, whereas such associations were not detected with lycopene and lutein/
zeaxanthin58. These studies, along with our present study, highlight the fact that various carotenoids may have 
non-overlapping and differential associations with insulin sensitivity in children, as previously reported in adults. 
However, the protective associations of the α- and β-carotenoids were not detectable in the presence of metabolic 
dysfunction. This concept needs further exploration, given our previous finding that fruit and vegetable juice 
concentrate supplementation could lead to increased serum β-carotene levels and improved insulin resistance 
in overweight prepubertal  boys74.
A balanced diet should incorporate a variety of fruits and vegetables as sources of different carotenoids. 
Orange colored vegetables such as carrots and green vegetables such as broccoli and spinach are rich sources 
of α-carotene and β-carotene75,76. Red-colored vegetables such as tomatoes are lycopene-rich, and orange-
colored fruits such as mandarins are rich in β-cryptoxanthin75,76. Our perplexing finding that the serum levels 
of β-cryptoxanthin, but not lycopene, being protective against many CMTs in the SAFARI children has prompted 
us to examine this issue further. Unlike many nutrients, lycopene’s bioavailability is increased by cooking, and 
processing and tomato-based products like ketchup and sauces are a common dietary source of  lycopene77. 
However, limited data exists on the relative health benefits of consuming whole tomatoes versus processed 
tomato products and lycopene supplements. Thus rigorous, well-controlled studies are needed to understand 
the differential effects of carotenoids in CMTs.
Reinforcing our results that indicate high heritability of serum carotenoid levels, genome-wide association 
analyses (GWAS) as well as candidate gene association studies (CGAS) have identified several genetic vari-
ants that could potentially contribute to inter-individual variability in carotenoid levels in the  body36. These 
genetic variants map to various stages in carotenoid metabolism, including absorption, conversion, fasting, 
and post-prandial blood concentrations, and tissue levels. Also, gene variants that alter lipid absorption and 
metabolism can influence circulating carotenoid  levels78. For example, genetic variants in BCO1, ABCA1, APOB, 
and LPL, have been implicated in fasting blood β-carotene concentrations, whereas genetic variants in RBP4 in 
fasting blood retinol concentrations (reviewed by Borel and  Desmarchelier79). Similarly, serum lycopene and 
β-cryptoxanthin levels may also be genetically  determined78,80. Such genetic variation could potentially lead to 
differences in carotenoid metabolism in global populations. However, irrespective of such genetic variability, 
consumption of a wide variety of fruits and vegetables need to be encouraged, given the broad protective effects 
of carotenoids on human health.
Conclusions
While dietary intake of fruits, vegetables, or supplements is critical for serum carotenoid levels, they are also 
determined by genetic influences that may alter their absorption, transport, tissue concentration, and utiliza-
tion of the carotenoids. Other modifying factors may include the differences in gut microbiota, socioeconomic 
strata, other metabolic conditions, and their interactions. Importantly, our findings suggest a connection between 
concentrations of certain serum carotenoids and insulin sensitivity patterns; increased serum concentrations of 
α- and β- carotenoids were shown to have maximal effects on insulin sensitivity. In summary, our study reveals 
that the serum carotenoids are under strong additive genetic influences; and, may have differential effects on 
susceptibility to childhood obesity and its related CMTs in children and adolescents.
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